Clinical Trial Update: Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Integrilin (eptifibatide) plus Ilomedin (iloprost) in combination with standard treatment for patients with severe pneumonia and severe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia
• Sepsis

Drugs mentioned

• Ilomedin (iloprost)
• Integrilin (Eptifibatide)

Snippet

Sponsor: Thrombologic ApS | Conditions: Pneumonia | Phase 2 | Status: TERMINATED